Plegridy Pen

Product manufactured by Biogen Inc.

Application Nr Approved Date Route Status External Links
BLA125499 None Subcutaneous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Plegridy Is Indicated For The Treatment Of Relapsing Forms Of Multiple Sclerosis (Ms), To Include Clinically Isolated Syndrome, Relapsing-Remitting Disease, And Active Secondary Progressive Disease, In Adults. Plegridy Is An Interferon Beta Indicated For The Treatment Of Relapsing Forms Of Multiple Sclerosis (Ms), To Include Clinically Isolated Syndrome, Relapsing-Remitting Disease, And Active Secondary Progressive Disease, In Adults ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Peginterferon Beta-1a

Comments